Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 89% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 82
- Reported
- 81
- Verified
- 75
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Proceed with caution
- Why
- Strong, vendor-documented performance numbers (SV recall 51.5%->87.8%, ~98% SNV phasing, $395/genome) and real early-access adoption (Broad Clinical Labs, GeneDx, Baylor), but short-read fundamentals, NovaSeq X lock-in, sample-quality sensitivity, and an incomplete TruPath<->ICM integration story warrant validation before reliance.
- Next
- Validate TruPath's SV recall and phasing on representative samples (meeting the 70% >10 kb / 40% >60 kb input guidance) against an established long-read baseline, and scope whether Connected Multiomics (research-only) meets the analysis use-case before building workflows on the 'connected' promise.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 7
- Tier 2
- 0
- Tier 3
- 0
- Supports
- 4
- Contradicts
- 1
- Context
- 2
- Latest observed
- 2026-02-24
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from mature to mature.
- 2026-09-22 Reading moved from mature to mature.